Missed Opportunities for Timely HIV Diagnosis Despite Routine Opt-Out Testing in Atlanta
Overview
In a large safety-net healthcare system in Atlanta, 70% of newly diagnosed HIV patients had no HIV test in the year prior to diagnosis despite routine opt-out testing. Missed testing opportunities were particularly common in primary care and nonsexual health visits, and were associated with more advanced disease at diagnosis.
Background
Undiagnosed HIV contributes disproportionately to new HIV transmissions, underscoring the importance of early diagnosis through expanded testing. The US CDC recommends routine opt-out HIV screening for all individuals aged 13–64 and annual testing for those at higher risk. Grady Health System in Atlanta implemented routine opt-out testing across emergency, inpatient, and outpatient settings to facilitate earlier diagnosis. However, missed opportunities for HIV testing remain a challenge, especially in settings outside sexual health and emergency departments.
Data Highlights
Metric
Value
Newly diagnosed individuals analyzed
713
Individuals with missed opportunity (MO)
499 (70%)
Total eligible encounters before diagnosis
1845
Missed testing opportunities (MTO)
1235 (67%)
Eligible individuals for testing (2015–2022)
531,848
Tests conducted
357,771
Individuals tested
199,004 (37.4%)
Reactive tests
4719 (1.3%)
New HIV diagnoses
861 (0.4%)
Key Findings
70% of newly diagnosed HIV patients had no HIV test in the year prior to diagnosis (missed opportunity).
67% of eligible healthcare encounters before diagnosis were missed testing opportunities where testing was indicated but not performed.
Sexual health–related encounters and STI testing were associated with significantly lower odds of missed opportunities (aOR 0.62 and 0.36 respectively).
Missed opportunities were linked to higher odds of advanced HIV disease at diagnosis (CD4 count <350 cells/mm3; aOR 1.8).
Primary care and outpatient encounters had higher odds of missed testing opportunities compared to emergency department visits (OR 0.67 for ED vs outpatient).
Despite routine opt-out testing, only 37.4% of eligible individuals were tested, with a low new diagnosis yield of 0.4%.
Clinical Implications
Routine opt-out HIV testing programs need optimization, particularly in primary care and nonsexual health settings, to reduce missed opportunities for earlier diagnosis. Enhancing provider awareness and integrating testing prompts in outpatient workflows may improve testing rates. Early diagnosis through improved testing can reduce late-stage presentations and potentially decrease HIV transmission.
Conclusion
Despite implementation of routine opt-out HIV testing in a high-volume safety-net system, most newly diagnosed individuals were not tested in the year prior to diagnosis, highlighting critical gaps in testing delivery. Targeted efforts to optimize testing in primary care and nonsexual health encounters are essential to improve early HIV detection.
References
CDC 2021 -- Ending the HIV Epidemic Initiative
Grady Health System Data 2015-2022 -- Routine Opt-Out HIV Testing Outcomes
by Sarah F Gruber, Megan Schwinne, Rishika Iytha, Emma J Hollenberg, Chad Robichaux, Valeria D Cantos, Jonathan A Colasanti, Anna Q Yaffee, Sara Turbow, Eric Leue, Andrés Camacho-González, Yun F Wang, Meredith H Lora
Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
